T. Rowe Price Investment Management
ATRC icon

T. Rowe Price Investment Management’s AtriCure ATRC Stock Holding History

T. Rowe Price Investment Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,198,849
Closed -$53.2M – 546
2022
Q4 		$53.2M Sell
1,198,849
-7,797
-0.6% -$326K 0.04% 350
2022
Q3 		$47.2M Buy
+1,206,646
New +$55.2M 0.04% 356

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Investment Management's ATRC Position: Q1 2023 in Review

T. Rowe Price Investment Management sold out of AtriCure (ATRC) in Q1 2023, closing a stake of 1,198,849 shares — an estimated $53.2M sold.

T. Rowe Price Investment Management first reported a position in ATRC in Q3 2022 and held it in 2 quarters. The position peaked at $53.2M in Q4 2022. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2023.

  • T. Rowe Price Investment Management reported no remaining AtriCure position as of Q1 2023 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 1,198,849 AtriCure shares in Q1 2023, an estimated $53.2M.
  • T. Rowe Price Investment Management first reported a position in AtriCure in Q3 2022 and held it in 2 quarters.
  • T. Rowe Price Investment Management's AtriCure position peaked at $53.2M in Q4 2022.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2023.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2023, filed 15 May 2023.